Literature DB >> 25266549

Task-evoked substantia nigra hyperactivity associated with prefrontal hypofunction, prefrontonigral disconnectivity and nigrostriatal connectivity predicting psychosis severity in medication naïve first episode schizophrenia.

Jong H Yoon1, Andrew J Westphal2, Michael J Minzenberg3, Tara Niendam2, J Daniel Ragland2, Tyler Lesh2, Marjorie Solomon4, Cameron S Carter5.   

Abstract

The widely cited prefrontal dysfunction - excess subcortical dopamine model of schizophrenia posits that prefrontal deficits give rise to cognitive impairments and the disinhibition of subcortical dopamine release underlying psychosis. While this has been one of the most influential schizophrenia models, only a handful of studies have provided evidence supporting it directly in patients with schizophrenia. We previously demonstrated task-evoked substantia nigra hyperactivity in the context of prefrontal hypofunction and prefrontonigral functional disconnectivity. In addition, nigrostriatal functional connectivity was identified as a potential marker of psychosis. Because patients in this prior study had chronic schizophrenia and were treated with antipsychotics, in the present study we tested whether these findings were confounded by illness chronicity and medication effects by seeking to reproduce these findings in an independent sample of antipsychotic naïve, first episode (FE) patients. We compared event-related fMRI activations from 12 FE patients with 15 demographically matched healthy control subjects during cognitive testing. We found substantia nigra hyperactivity associated with prefrontal hypofunction and prefrontonigral functional disconnectivity, as well as the magnitude of nigrostriatal functional connectivity positively correlating with severity of psychosis. This study adds to the body of evidence supporting the prefrontal-dopamine model of schizophrenia and further validates nigrostriatal functional connectivity as a marker of psychosis. Published by Elsevier B.V.

Entities:  

Keywords:  Basal ganglia; Dopamine; Prefrontal cortex; Psychosis; Striatum; Substantia nigra; fMRI

Mesh:

Year:  2014        PMID: 25266549      PMCID: PMC6921934          DOI: 10.1016/j.schres.2014.09.022

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  38 in total

1.  Detecting activations in PET and fMRI: levels of inference and power.

Authors:  K J Friston; A Holmes; J B Poline; C J Price; C D Frith
Journal:  Neuroimage       Date:  1996-12       Impact factor: 6.556

2.  Divide and conquer: a defense of functional localizers.

Authors:  Rebecca Saxe; Matthew Brett; Nancy Kanwisher
Journal:  Neuroimage       Date:  2006-04-24       Impact factor: 6.556

3.  Implications of normal brain development for the pathogenesis of schizophrenia.

Authors:  D R Weinberger
Journal:  Arch Gen Psychiatry       Date:  1987-07

Review 4.  Dopamine in schizophrenia: a review and reconceptualization.

Authors:  K L Davis; R S Kahn; G Ko; M Davidson
Journal:  Am J Psychiatry       Date:  1991-11       Impact factor: 18.112

5.  Elevated dopa decarboxylase activity in living brain of patients with psychosis.

Authors:  J Reith; C Benkelfat; A Sherwin; Y Yasuhara; H Kuwabara; F Andermann; S Bachneff; P Cumming; M Diksic; S E Dyve; P Etienne; A C Evans; S Lal; M Shevell; G Savard; D F Wong; G Chouinard; A Gjedde
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-22       Impact factor: 11.205

6.  Negative symptoms in schizophrenia. Definition and reliability.

Authors:  N C Andreasen
Journal:  Arch Gen Psychiatry       Date:  1982-07

7.  Impaired prefrontal-basal ganglia functional connectivity and substantia nigra hyperactivity in schizophrenia.

Authors:  Jong H Yoon; Michael J Minzenberg; Sherief Raouf; Mark D'Esposito; Cameron S Carter
Journal:  Biol Psychiatry       Date:  2013-01-03       Impact factor: 13.382

Review 8.  Inverted-U-shaped dopamine actions on human working memory and cognitive control.

Authors:  Roshan Cools; Mark D'Esposito
Journal:  Biol Psychiatry       Date:  2011-05-04       Impact factor: 13.382

9.  Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method.

Authors:  A Breier; T P Su; R Saunders; R E Carson; B S Kolachana; A de Bartolomeis; D R Weinberger; N Weisenfeld; A K Malhotra; W C Eckelman; D Pickar
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-18       Impact factor: 11.205

10.  Specificity of prefrontal dysfunction and context processing deficits to schizophrenia in never-medicated patients with first-episode psychosis.

Authors:  Angus W MacDonald; Cameron S Carter; John G Kerns; Stefan Ursu; Deanna M Barch; Avram J Holmes; V Andrew Stenger; Jonathan D Cohen
Journal:  Am J Psychiatry       Date:  2005-03       Impact factor: 18.112

View more
  12 in total

1.  Activation of brainstem and midbrain nuclei during cognitive control in medicated patients with schizophrenia.

Authors:  Stefanie Köhler; Gerd Wagner; Karl-Jürgen Bär
Journal:  Hum Brain Mapp       Date:  2018-09-05       Impact factor: 5.038

2.  Ultrastructural evidence for glutamatergic dysregulation in schizophrenia.

Authors:  Rosalinda C Roberts; Lesley A McCollum; Kirsten E Schoonover; Samuel J Mabry; Joy K Roche; Adrienne C Lahti
Journal:  Schizophr Res       Date:  2020-01-31       Impact factor: 4.939

3.  Nigral Stress-Induced Dopamine Release in Clinical High Risk and Antipsychotic-Naïve Schizophrenia.

Authors:  Huai-Hsuan Tseng; Jeremy J Watts; Michael Kiang; Ivonne Suridjan; Alan A Wilson; Sylvain Houle; Pablo M Rusjan; Romina Mizrahi
Journal:  Schizophr Bull       Date:  2018-04-06       Impact factor: 9.306

4.  Protein Markers of Neurotransmitter Synthesis and Release in Postmortem Schizophrenia Substantia Nigra.

Authors:  Kirsten E Schoonover; Lesley A McCollum; Rosalinda C Roberts
Journal:  Neuropsychopharmacology       Date:  2016-08-23       Impact factor: 7.853

5.  Functional Connectivity of the Striatum in Schizophrenia and Psychotic Bipolar Disorder.

Authors:  Nicole R Karcher; Baxter P Rogers; Neil D Woodward
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2019-06-12

6.  Abnormal Resting-State Connectivity in a Substantia Nigra-Related Striato-Thalamo-Cortical Network in a Large Sample of First-Episode Drug-Naïve Patients With Schizophrenia.

Authors:  Matteo Martino; Paola Magioncalda; Hua Yu; Xiaojing Li; Qiang Wang; Yajing Meng; Wei Deng; Yinfei Li; Mingli Li; Xiaohong Ma; Timothy Lane; Niall W Duncan; Georg Northoff; Tao Li
Journal:  Schizophr Bull       Date:  2018-02-15       Impact factor: 9.306

7.  Evidence for altered excitatory and inhibitory tone in the post-mortem substantia nigra in schizophrenia.

Authors:  Samuel J Mabry; Lesley A McCollum; Charlene B Farmer; Emma S Bloom; Rosalinda C Roberts
Journal:  World J Biol Psychiatry       Date:  2019-06-04       Impact factor: 4.132

8.  Dysfunctional Striatal Systems in Treatment-Resistant Schizophrenia.

Authors:  Thomas P White; Rebekah Wigton; Dan W Joyce; Tracy Collier; Alex Fornito; Sukhwinder S Shergill
Journal:  Neuropsychopharmacology       Date:  2015-09-09       Impact factor: 7.853

9.  Evaluation of fronto-striatal networks during cognitive control in unmedicated patients with schizophrenia and the effect of antipsychotic medication.

Authors:  Elyse J Cadena; David M White; Nina V Kraguljac; Meredith A Reid; Adrienne C Lahti
Journal:  NPJ Schizophr       Date:  2018-05-07

Review 10.  Diverse definitions of the early course of schizophrenia-a targeted literature review.

Authors:  Richard Newton; Alice Rouleau; Anna-Greta Nylander; Jean-Yves Loze; Henrike K Resemann; Sara Steeves; Benedicto Crespo-Facorro
Journal:  NPJ Schizophr       Date:  2018-10-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.